Table 2. Data of different outcomes are reported as median and 95% CI for LOAD, posture, mobility, pain and ROM and mean and 95% CI for GLS, AC and Von Frey grams, at baseline and during different groups and times of administration.
| Baseline | UCII®-BW (4week) |
UCII®-BW (8week) |
Washout | Placebo (4weeks) |
Placebo (8week) |
|
|---|---|---|---|---|---|---|
| Owner assessment | ||||||
| Load | 17 (12–21) | 11 (8–17) | 13 (8–15) | 14 (10–19) | 15 (9–19) | 15 (8–21) |
| Veterinarian assessment | ||||||
| Posture | 2 (2–2) | 2 (2–2) | 2 (2–2) | 2 (1.26–2 | 2 (2–2) | 2 (2–2) |
| Mobility | 2 (2–3) | 2 (2–2.5) | 2 (2–2) | 2 (2–2.5) | 2 (2–2.5) | 2 (2–2.5) |
| Pain | 2 (2–3) | 2 (2–3) | 2 (2–2.4) | 3 (3–1) | 2 (1.75–3) | 3 (2–3.4) |
| ROM | 3 (2–3) | 2 (2–3) | 2 (2–3) | 2 (2–3) | 3 (2–3) | 3 (2–3) |
| Instrumental assessment | ||||||
| GLS | 93 (90–97) |
96 (92–105) |
99 (89–102) |
92 (87–101) |
95 (89–101) |
98 (90–102) |
| AC Q1 Q2 Q3 |
6120 (4900–7340) 6178 (5022–7333) 6185 (4898–7472) |
6645 (4410–8880) 6975 (4603–9347) 6916 (4677–9155) |
5963 (3426–8500) 6077 (3460–8696) 5991 (3413–8569) |
7477 (4657–10297) 7570 (4880–10260) 7570 (4870–10268) |
7657 (2486–12829) 7740 (2685–12794) 7766 (2746–12786) |
7058 (2972–11143) 7117 (3132–11102) 7193 (3275–11112) |
| Von Frey (g) |
355 (275–436) |
317 (234–400) |
393 (293–493) |
311 (251–372) |
212 (153–271) |
327 (227–428) |
No differences were found between times and groups of supplementations (p = 0.38).